UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer

Annals of oncology, 2009-07, Vol.20 (7), p.1223-1229

2009

Volltextzugriff (PDF)

Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer

Annals of oncology, 2013-02, Vol.24 (2), p.420-428

2013

Volltextzugriff (PDF)

A phase II study of high-dose bevacizumab in combination with irinotecan, 5-fluorouracil, leucovorin, as initial therapy for advanced colorectal cancer: results from the eastern cooperative oncology group study E2200

Annals of oncology, 2006-09, Vol.17 (9), p.1399-1403

2006

Volltextzugriff (PDF)

Mortality Associated With Irinotecan Plus Bolus Fluorouracil/Leucovorin: Summary Findings of an Independent Panel

Journal of clinical oncology, 2001-09, Vol.19 (18), p.3801-3807

2001

Volltextzugriff (PDF)

Relationship of increased aurora kinase A gene copy number, prognosis and response to chemotherapy in patients with metastatic colorectal cancer

British journal of cancer, 2012-02, Vol.106 (4), p.748-755

2012

Volltextzugriff (PDF)

Phase I study of capecitabine combined with radioembolization using yttrium-90 resin microspheres (SIR-Spheres) in patients with advanced cancer

British journal of cancer, 2014-07, Vol.111 (2), p.265-271

2014

Volltextzugriff (PDF)

The relationships among knowledge, self-efficacy, preparedness, decisional conflict, and decisions to participate in a cancer clinical trial

Psycho-oncology (Chichester, England), 2013-03, Vol.22 (3), p.481-489

2013

Volltextzugriff (PDF)

Attitudinal barriers to participation in oncology clinical trials: factor analysis and correlates of barriers

European journal of cancer care, 2015-01, Vol.24 (1), p.28-38

2015

Volltextzugriff (PDF)

Preliminary studies of a novel oral fluoropyrimidine carbamate: capecitabine

Journal of clinical oncology, 1998-05, Vol.16 (5), p.1795-1802

1998

Volltextzugriff (PDF)

Oral fluoropyrimidines in the treatment of colorectal cancer

European journal of cancer (1990), 1998-09, Vol.34 (10), p.1509-1513

Meropol, N.J

1998

Volltextzugriff (PDF)

American Society of Clinical Oncology Clinical practice guidelines for the use of chemotherapy and radiotherapy protectants

Journal of clinical oncology, 1999-10, Vol.17 (10), p.3333-3355

1999

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Trial of Gemcitabine in Patients With Hepatic or Renal Dysfunction: Cancer and Leukemia Group B 9565

Journal of clinical oncology, 2000-07, Vol.18 (14), p.2780-2787

2000

Volltextzugriff (PDF)

Patient-physician discordance in goals of care for patients with advanced cancer

Current oncology (Toronto), 2019-12, Vol.26 (6), p.370-379

2019

Volltextzugriff (PDF)

Circulating cytokines and monocyte subpopulations as biomarkers of outcome and biological activity in sunitinib-treated patients with advanced neuroendocrine tumours

British journal of cancer, 2015-03, Vol.112 (7), p.1199-1205

2015

Volltextzugriff (PDF)

Impact of Quality of Life on Patient Expectations Regarding Phase I Clinical Trials

Journal of clinical oncology, 2000-01, Vol.18 (2), p.421-428

2000

Volltextzugriff (PDF)

The Base Excision Repair Enzyme MED1 Mediates DNA Damage Response to Antitumor Drugs and Is Associated with Mismatch Repair System Integrity

Proceedings of the National Academy of Sciences - PNAS, 2003-12, Vol.100 (25), p.15071-15076

2003

Volltextzugriff (PDF)

Daily subcutaneous injection of low-dose interleukin 2 expands natural killer cells in vivo without significant toxicity

Clinical cancer research, 1996-04, Vol.2 (4), p.669-677

1996

Volltextzugriff (PDF)

Constructs of burden of illness in older patients with breast cancer: a comparison of measurement methods

Health services research, 2001-12, Vol.36 (6 Pt 1), p.1085-1107

2001

Volltextzugriff (PDF)

Interleukin‐2 enhances the natural killer cell response to Herceptin‐coated Her2 / neu‐positive breast cancer cells

European journal of immunology, 2001-10, Vol.31 (10), p.3016-3025

2001

Volltextzugriff (PDF)

Evaluation of natural killer cell expansion and activation in vivo with daily subcutaneous low-dose interleukin-2 plus periodic intermediate-dose pulsing

Cancer Immunology, Immunotherapy, 1998-08, Vol.46 (6), p.318-326

1998

Volltextzugriff (PDF)

The Influence of Granulocyte Macrophage Colony-Stimulating Factor and Prior Chemotherapy on the Immunological Response to a Vaccine (ALVAC-CEA B7.1) in Patients with Metastatic Carcinoma

Clinical cancer research, 2001-05, Vol.7 (5), p.1181-1191

2001

Volltextzugriff (PDF)

Paradoxical Correlations of Cyclin-dependent Kinase Inhibitors p21waf1/cip1 and p27kip1 in Metastatic Colorectal Carcinoma

Clinical cancer research, 1999-05, Vol.5 (5), p.1057-1062

1999

Volltextzugriff (PDF)

Intravenous Ifosfamide/Mesna Is Associated with Depletion of Plasma Thiols without Depletion of Leukocyte Glutathione

Clinical cancer research, 2000-04, Vol.6 (4), p.1314-1321

2000

Volltextzugriff (PDF)

A phase I and pharmacokinetic study of oral uracil, ftorafur, and leucovorin in patients with advanced cancer

Cancer chemotherapy and pharmacology, 1996, Vol.37 (6), p.581-586

1996

Volltextzugriff (PDF)

Age and sex are independent predictors of 5‐fluorouracil toxicity. Analysis of a large scale phase III trial

Cancer, 1995-01, Vol.75 (1), p.11-17

1995

Volltextzugriff (PDF)

1 – 25 von 208

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(200)
Mit Volltextzugriff
(190)

Publikationsform

Artikel
(206)
Buchkapitel
(2)

Sprache

Englisch
(208)

Erscheinungsjahr

n.n

Thema

Humans
(112)
Science & Technology
(111)
Life Sciences & Biomedicine
(110)
Oncology
(91)
Female
(77)
Biological And Medical Sciences
(73)
Medical Sciences
(71)
Middle Aged
(70)
Male
(69)
Aged
(68)
Adult
(53)
Pharmacology. Drug Treatments
(52)
Antineoplastic Agents
(45)
Chemotherapy
(40)
Treatment Outcome
(29)
Tumors
(27)
Aged, 80 And Over
(23)
Colorectal Neoplasms - Drug Therapy
(22)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(21)
Neoplasms - Drug Therapy
(21)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer

Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer

A phase II study of high-dose bevacizumab in combination with irinotecan, 5-fluorouracil, leucovorin, as initial therapy for advanced colorectal cancer: results from the eastern cooperative oncology group study E2200

Mortality Associated With Irinotecan Plus Bolus Fluorouracil/Leucovorin: Summary Findings of an Independent Panel

Relationship of increased aurora kinase A gene copy number, prognosis and response to chemotherapy in patients with metastatic colorectal cancer

Phase I study of capecitabine combined with radioembolization using yttrium-90 resin microspheres (SIR-Spheres) in patients with advanced cancer

The relationships among knowledge, self-efficacy, preparedness, decisional conflict, and decisions to participate in a cancer clinical trial

Attitudinal barriers to participation in oncology clinical trials: factor analysis and correlates of barriers

Preliminary studies of a novel oral fluoropyrimidine carbamate: capecitabine

Oral fluoropyrimidines in the treatment of colorectal cancer

American Society of Clinical Oncology Clinical practice guidelines for the use of chemotherapy and radiotherapy protectants

Phase I and Pharmacokinetic Trial of Gemcitabine in Patients With Hepatic or Renal Dysfunction: Cancer and Leukemia Group B 9565

Patient-physician discordance in goals of care for patients with advanced cancer

Circulating cytokines and monocyte subpopulations as biomarkers of outcome and biological activity in sunitinib-treated patients with advanced neuroendocrine tumours

Impact of Quality of Life on Patient Expectations Regarding Phase I Clinical Trials

The Base Excision Repair Enzyme MED1 Mediates DNA Damage Response to Antitumor Drugs and Is Associated with Mismatch Repair System Integrity

Daily subcutaneous injection of low-dose interleukin 2 expands natural killer cells in vivo without significant toxicity

Constructs of burden of illness in older patients with breast cancer: a comparison of measurement methods

Interleukin‐2 enhances the natural killer cell response to Herceptin‐coated Her2 / neu‐positive breast cancer cells

Evaluation of natural killer cell expansion and activation in vivo with daily subcutaneous low-dose interleukin-2 plus periodic intermediate-dose pulsing

The Influence of Granulocyte Macrophage Colony-Stimulating Factor and Prior Chemotherapy on the Immunological Response to a Vaccine (ALVAC-CEA B7.1) in Patients with Metastatic Carcinoma

Paradoxical Correlations of Cyclin-dependent Kinase Inhibitors p21waf1/cip1 and p27kip1 in Metastatic Colorectal Carcinoma

Intravenous Ifosfamide/Mesna Is Associated with Depletion of Plasma Thiols without Depletion of Leukocyte Glutathione

A phase I and pharmacokinetic study of oral uracil, ftorafur, and leucovorin in patients with advanced cancer

Age and sex are independent predictors of 5‐fluorouracil toxicity. Analysis of a large scale phase III trial

Suchergebnisse filtern